The Emergency Use Authorization of Pharmaceuticals History and Utility During the COVID-19 Pandemic

Tran, A. and Witek, T. (2021). The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic. Pharmaceutical Medicine. 35(4): 203-213.
The authors examined the history of emergency use authorizations (EUAs) since their inception in 2004, with a particular focus on their use during the COVID-19 pandemic. EUAs facilitated the rollout of COVID-19 vaccines and allowed a pause for safety review of one vaccine. The authors also discussed new drug/vaccine application approvals.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.